NYSE:BIOLife Sciences
Is It Time To Reconsider Bio-Rad Laboratories (BIO) After Its Prolonged Share Price Slump
If you are wondering whether Bio-Rad Laboratories is offering good value at around US$278.44 per share, this article walks through what the current price might be implying about the business.
The stock has had a mixed run, with a 2.6% gain over the last 7 days, a 7.1% decline over 30 days, an 8.8% decline year to date, a 5.0% return over 1 year, a 44.6% decline over 3 years, and a 51.0% decline over 5 years.
These ups and downs have kept valuation in focus for many investors, especially as...